what could this little gem be?At this moment, rumors indicate Johnson & Johnson and Google are plotting takeover bids for a tiny $2 microcap by April 15th. Although this company is small, it holds critical patents that could impact 27 million Americans and unlock an expected $18 billion market. In addition, this company is part of a market sector responsible for rare and exceptional trades big enough to turn $1,000 into $1.6 million. Institutions and insiders closest to the action have already grabbed up 96% of shares in advance of a takeover battle. Trading volume just surged a staggering 2,500% on the news. This is just getting started…Any hints Travis?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I would also like to know who this is. I have gotten this info from at least 3 different sources. So, Travis do your stuff and sniff this out.
I also would like to know about this company. Thank you for your insight. You are fabulous in the work you put out to us. You are great gumshoe. You have saved me many times. Before I invest I check the status of each company weather it is worth investing in, with you. Thank you for helping me.
$TRXC this is very old, check archives.
http://www.stockgumshoe.com/reviews/bioscience-millionaire/whats-the-bionic-surgeon-looking-for-imminent-fda-approval/
I agree it’s TRXC….Again! The FDA was supposed to provide an answer by end of 1st quarter then it got pushed to mid April, which everyone seems to think will be April 15th. At the time there were rumors that JNJ was going to offer a takeover bid for TRXC’s Surgibot system because they wanted to get into the surgical robotics field, then I started hearing they were going possibly get together with Google to make their own. Haven’t heard anything yet except about possible FDA approval. Even if approved, I don’t believe TRXC even has a sales force in place. They may just install it at a few significant medical facilities to use as “Beta” sites, that is where they would take potential customers to demo instead of providing a demo unit. Don’t know really what to think at this point. Absolutely no new information yet they’re acting as if this is a brand new pump! Even with FDA approval it’s going to take them a while to get it up and going, unless they’ve been working behind the scenes and presuming FDA approval is imminent. Still deciding if I should get back in but again it’s not a $2.00 stock anymore, the last time I looked it was @ $5.15 at the close of the day today Tuesday 4.5.16